Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Rated “Moderate Buy” by Sell-Side Brokerages
Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, nine have assigned a buy recommendation and […]
13 Oct 08:29 · The Cerbat Gem